Although many studies have evaluated overall drug development success rates, predominantly by assessing therapeutics’ phase transition rates and probabilities of approval, none have reported trial-level success rates to date. Here, we delve into this area to take a closer look at trial-level success with an eye toward identifying strategies that may correlate with success.
Drug development is a risky endeavor, so just what are the odds of running a successful trial? Many studies have evaluated overall drug
development success rates, predominantly by assessing therapeutics’ phase transition rates and probabilities of approval, yet none have reported trial-level success rates to date. We delve into this question of trial-level success to identify strategies that may correlate with success.
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: